$TWST (+0,68%) is showing strong growth momentum with 23% annual sales gain and expanding relevance in synthetic DNA and genomics. Right now, the stock is coming off its recent lows, the biotech sector is heating up again, and Twist’s pipeline positions it for big upside as more labs and developers pivot to synthetic biology platforms. With the tech-driven rebound and innovation tailwinds, this could be a great entry for the next leg higher.

🇮🇹 Dopo i risultati Q3-2025, Twist Bioscience $TWST (+0,68%) ha perso il 15%… ma i fondamentali sono solidi:

📈 Ricavi in crescita da 10 trimestri consecutivi

💰 Margini lordi >50%

📅 Profitto atteso già dal prossimo anno

Hanno lasciato il business del DNA storage per concentrarsi sul core più redditizio.

💡 Per me è un voto di fiducia nel futuro dell’azienda.

🇬🇧 After Q3-2025 earnings, Twist Bioscience $TWST (+0,68%) dropped 15%… but the fundamentals are strong:

📈 Revenue up for 10 consecutive quarters

💰 Gross margin above 50%

📅 Profitability expected next year

They exited the DNA storage business to focus on their most profitable core.

💡 For me, it’s a vote of confidence in the company’s future.